February 2016

Patient Care

Chemotherapy regimen following radiation treatment improves survival for adults with low-grade gliomas
Study participants who received PCV chemotherapy plus radiation therapy showed statistically significant improvement in overall survival, compared with those who received only radiation therapy — 13.3 years versus 7.8 years median survival time.

Localization and diagnostic tools and techniques promise less invasive treatments of lung cancer
Collaboration between interventional pulmonology, radiation oncology and thoracic surgery specialists has resulted in successful localization and management of pulmonary nodules smaller than 1 centimeter.

Research

Marker helps confirm the difficult diagnosis of vitreoretinal lymphoma
Research indicates that MYD88 L265P constitutive activating mutations are present in at least some cases of the diffuse large B-cell lymphoma form of vitreoretinal lymphoma.

Epigenomic fingerprint helps identify and possibly stop the progression of many late-stage cancers
Studies of the epigenomic fingerprint identified in kidney cancer suggest a common pathway that may improve the diagnosis and treatment of advanced disease across a variety of cancer types: bladder, blood, bone, brain and lung.


See all Cancer Clinical Trials at Mayo Clinic

Back to Top

Education

Mayo Clinic Oncology Review 2016
July 23, 2016, in Minneapolis
This program provides an overview of the most recent advances in the treatment of various oncologic malignancies, based on abstracts presented at the June 2016 annual meeting of the American Society of Clinical Oncology.

Mayo Clinic Angiogenesis and Tumor Microenvironment Symposium: From Translational Research to Clinical Practice 2016
Nov. 18-20, 2016 in Amelia Island, Fla.
The symposium brings together science and clinical experts to exchange ideas involving basic biology and pathways of angiogenesis and microenvironment in disease processes, used for specific targeting of tumor blood vessels and stroma.


See all Hematology and Oncology Continuous Professional Development courses

In the Video Center

Methylated DNA Markers and Whole Body Cancer Screening
John B. Kisiel, M.D., discusses a study that identified sources of cancer in patients' gastrointestinal tracts by analyzing DNA markers from tumors. Screening for cancer anywhere in the body with a noninvasive blood test or stool sample may be possible.


View videos by specialty and Grand Rounds presentations online

Back to Top

Consults & Referrals

Resources

• Career Opportunities
   
• Clinical Trials at Mayo Clinic
   
• Mayo School of Continuous Professional Development

Back to Top